Please assess the completion status of the following clinical trial:

Trial Title: Effects of Marijuana on Symptoms of OCD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age 21-55~* Physically healthy~* Diagnosed with OCD~* Current marijuana user~* Women of childbearing potential must be using an effective form of birth control~* Not currently taking psychotropic medications~* Ability to provide informed consent~Exclusion Criteria:~* History of any significant medical condition that may increase the risk of participation~* Females who are pregnant or nursing~* If female, not pregnant~* Current or lifetime history of psychiatric disorders other than OCD that may increase the risk of participation~* Current substance use disorder~* Severe depression or positive urine toxicology (other than THC) at screening, or any adverse reaction to a cannabinoid~* Patients who are seeking treatment for substance abuse~* Patients who are planning to begin a course of cognitive-behavioral therapy within 8 weeks of beginning the study

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- High THC/Low CBD Marijuana (Type: EXPERIMENTAL): This condition involves the ingestion of marijuana with a high THC (5-10%) and low CBD (\<1%) content.
- Low THC/High CBD Marijuana (Type: EXPERIMENTAL): This condition involves the ingestion of marijuana with a low THC (\<1%) and high CBD (\>10%) content.
- No THC/No CBD (Type: PLACEBO_COMPARATOR): This condition involves the ingestion of a placebo control with no THC and no CBD content.

Based on this trial design, predict the completion outcome and termination type (if applicable).